IBUTAMOREN (MK-677) · 25 MG | Estimulación de GH. Más Masa, Mejor Recuperación.

Key Benefits of Ibutamoren (MK-677) Pulsatile Growth Hormone Stimulation Ibutamoren acts as a ghrelin receptor (GHS-R1a) agonist, mimicking ghrelin&#039;s action to stimulate the pituitary gland to release GH in natural pulses. This mechanism maintains hormonal axis integrity, unlike exogenous GH administration which can suppress endogenous production. MK-677 has a binding affinity to the ghrelin receptor with a Ki of approximately 7.24 nM and a Kd of 0.14 nM, demonstrating its high potency. Increased IGF-1 Levels GH stimulation leads to a significant increase in insulin-like growth factor type 1 (IGF-1) levels. Clinical studies have demonstrated that 25 mg daily of MK-677 increases IGF-1 by up to 88% after four weeks. This IGF-1 increase is responsible for much of the compound&#039;s anabolic and recovery effects. Increased Fat-Free Mass and Body Mass In a one-year reference study, MK-677 (25 mg/day) resulted in a 1.1 kg increase in fat-free mass (muscle) and a 2.7 kg increase in total body mass compared to placebo. A study in healthy older adults demonstrated that MK-677 increased fat-free mass by 1.6 kg compared to placebo. The combination of lean mass gain and muscle preservation makes MK-677 a valuable tool for improving body composition. Improved Deep and REM Sleep MK-677 has been shown to significantly improve sleep quality. In young subjects, it increased slow-wave sleep (stage IV) duration by approximately 50% and REM sleep by over 20%. In older adults, a nearly 50% increase in REM sleep was observed with a reduction in REM latency. The frequency of sleep deviations decreased from 42% under placebo to 8% under high-dose MK-677. This sleep effect is one of the most notable and frequently reported by users. Enhanced Recovery and Tissue Repair By elevating GH and IGF-1 levels, MK-677 promotes protein synthesis and repair of damaged tissues. The PI3K/Akt/mTOR pathway, activated by IGF-1, is a central regulator of cell growth and protein synthesis, contributing to post-training recovery. This effect is especially beneficial for athletes and active individuals. Increased Bone Mineral Density Studies have demonstrated that MK-677 increases bone formation markers. In combination with alendronate, a 4.2% increase in bone mineral density at the femoral neck was observed at 18 months. This effect suggests potential long-term bone health benefits

Function and Mechanism of Action of Ibutamoren (MK-677) Ibutamoren (MK-677) is a non-peptide, orally active growth hormone secretagogue that acts as a ghrelin receptor (GHS-R1a) agonist. Unlike injectable peptides, MK-677 is a small molecule that can be administered orally and has high affinity for its target receptor. Detailed Mechanism of Action: Ghrelin Receptor (GHS-R1a) Binding: Ibutamoren binds to the ghrelin receptor (GHS-R1a) with a Ki affinity of ~7.24 nM and a Kd of 0.14 nM, demonstrating high potency and selectivity. Binding to the GHS-R1a receptor activates several intracellular signaling pathways: Gq/11 Pathway: Leads to activation of phospholipase C (PLC), generating inositol trisphosphate (IP3) and diacylglycerol (DAG), resulting in increased intracellular calcium. Gi/o Pathway: Activation of this pathway can lead to inhibition of adenylyl cyclase, reducing cAMP levels. β-arrestin Pathway: This pathway can mediate a distinct set of cellular responses independent of G proteins. GH Release Stimulation: GHS-R1a receptor activation in the hypothalamus and pituitary stimulates growth hormone (GH) release in natural pulses, mimicking the body&#039;s physiological rhythm. This pulsatile stimulation maintains hypothalamic-pituitary axis integrity, unlike exogenous GH administration. IGF-1 Increase: Released GH acts on the liver and peripheral tissues to stimulate insulin-like growth factor type 1 (IGF-1) production. IGF-1 activates the PI3K/Akt/mTOR and Ras/MEK/ERK pathways, which are central regulators of cell growth, proliferation, survival, and protein synthesis. Sleep Effects: Ghrelin receptor activation and GH increase can influence sleep cycles. The Copinschi et al. (1997) study demonstrated that MK-677 significantly increases slow-wave sleep (stage IV) duration and REM sleep. Comparison with GHRPs and Exogenous GH: Unlike GHRP peptides (such as GHRP-2 or GHRP-6), MK-677 is a small oral molecule with a longer half-life. Compared to exogenous GH administration, MK-677 stimulates endogenous release in natural pulses, avoiding hormonal axis suppression.

How to Use Ibutamoren (MK-677) Route of Administration: Oral. Ibutamoren is administered as tablets for oral ingestion. Tablets should be swallowed whole with water. Dosage: Dosage should be determined by a physician according to indications and patient condition. General dosage guidelines for ibutamoren include: Standard Dose: 10-25 mg per day. Research Dose: 25 mg per day is the most studied dose in clinical trials. Timing of Administration: Recommended before bedtime to take advantage of the natural GH peak during sleep and minimize appetite increase. Frequency: Daily administration. Ibutamoren has a long half-life (approximately 24 hours), allowing for single daily administration. Treatment Duration: Depends on the type and intensity of symptoms. For GH stimulation and mass gain cycles, cycles of 8-24 weeks are recommended. Clinical studies have evaluated its use for up to one year. Storage: Store in a cool, dry place, protected from light and at room temperature. Keep out of reach of children. Important Notice: Product intended FOR HUMAN USE under medical supervision. Ibutamoren is an investigational compound and its use must be supervised by a physician. It is prohibited by the World Anti-Doping Agency (WADA). Reported side effects include increased appetite, mild fluid retention, increased blood glucose levels (5-10%), and decreased insulin sensitivity. Studies in older adults have reported rare cases of hypertension and heart failure. Not recommended in people with diabetes, metabolic syndrome, or cardiovascular disease.

Ingredients of Ibutamoren (MK-677) Active Ingredient: Ibutamoren (MK-677): A non-peptide, orally active growth hormone secretagogue that acts as a ghrelin receptor (GHS-R1a) agonist. It is a small molecule that stimulates natural, pulsatile GH and IGF-1 release. Molecular formula: C₂₇H₃₆N₄O₅S. Molecular weight: 528.66 g/mol. CAS: 159752-10-0. Excipients: Each 25 mg tablet contains the following excipients (according to standard formulations): Lactose monohydrate: Used as an excipient and bulking agent. Microcrystalline cellulose: Used as a bulking agent and disintegrant. Corn starch: Used as a disintegrant and bulking agent. Magnesium stearate: Used as a lubricant. Colloidal anhydrous silica: Used as a flow agent. Note: Specific excipients may vary by manufacturer. Consult the product leaflet for the complete list of excipients. Note for Users: This product is a pharmaceutical-grade compound manufactured under strict quality control standards (GMP) by Kinetix Pharma, in the Czech Republic. Each package contains 60 tablets of 25 mg each. Ibutamoren is prohibited by the World Anti-Doping Agency (WADA)

Onset Time &amp; Expected Results of Ibutamoren (MK-677) Onset of Action (Days to Weeks): Ibutamoren begins acting within the first hours or days after oral administration. Effects on GH levels are observed from the first dose, as documented in the Svensson et al. study where peak GH increased significantly after the initial dose. Effects on sleep quality can be notable within the first days. Measurable Benefits (2-4 Weeks): The first measurable changes in IGF-1 levels begin to be visible within the first 2-4 weeks of consistent use. After two weeks, IGF-1 increased by 55% and after four weeks by 88%. Effects on body composition are observed from 4-8 weeks. Full Effect (12-24 Weeks): For maximum lean mass increase and complete body composition improvement, the full effect requires 12-24 weeks of consistent use according to the research protocol. One-year studies have demonstrated sustained increases in fat-free mass and body mass. Factors Influencing Results: The speed and magnitude of results depend on dose administered, adherence to the treatment protocol, the patient&#039;s baseline condition, nutrition quality, and training type.

Clinical Research &amp; 3rd Party Test Results of Ibutamoren (MK-677) Scientific evidence on ibutamoren comes from decades of research, including multiple Phase II and III clinical trials. Clinical Evidence in Humans: Body Composition (Nass et al. 2008): In a one-year study in healthy older adults, MK-677 (25 mg/day) resulted in a 1.1 kg increase in fat-free mass and a 2.7 kg increase in total body mass compared to placebo. Effects were maintained over two years of follow-up. Sleep (Copinschi et al. 1997): In young subjects, MK-677 (25 mg) increased slow-wave sleep (stage IV) duration by approximately 50% and REM sleep by over 20%. In older adults, a nearly 50% increase in REM sleep was observed. The frequency of sleep deviations decreased from 42% to 8%. Hormones (Svensson et al. 1998): In obese men, MK-677 (25 mg) for 8 weeks increased peak GH to 14.3 mIU/L vs. 0.9 mIU/L in placebo, and increased IGF-1 by 40%. Hip Fracture Recovery: In elderly hip fracture patients, MK-677 increased IGF-1 by 84%, although no significant functional improvements were shown. The study was terminated due to a congestive heart failure case. Osteoporosis: In postmenopausal women, MK-677 increased bone formation markers and, in combination with alendronate, improved femoral neck bone mineral density. Safety Considerations: Common Side Effects: Increased appetite, mild fluid retention (extremity edema), increased blood glucose (5-10%), and decreased insulin sensitivity. Risks: In older adults, rare cases of hypertension and heart failure have been reported. Regulatory Status: Ibutamoren is not FDA-approved for any medical use. It is prohibited by the World Anti-Doping Agency (WADA). Kinetix Pharma Quality Standards: Pharmaceutical Grade: Pharmaceutical-grade compound for human use. Manufacturing: Manufactured in the Czech Republic under strict GMP standards by Kinetix Pharma. Quality Control: Each batch is subjected to quality control testing to ensure purity and potency.

Product Details

IBUTAMOREN (MK-677) · 25 MG | Estimulación de GH. Más Masa, Mejor Recuperación.

IBUTAMOREN (MK-677) · 25 MG | Estimulación de GH. Más Masa, Mejor Recuperación.

Build Your Stack

Frequently Asked Questions